CorMedix (CRMD) Depreciation & Amortization (CF) (2016 - 2025)
CorMedix has reported Depreciation & Amortization (CF) over the past 15 years, most recently at $294096.0 for Q4 2025.
- Quarterly results put Depreciation & Amortization (CF) at $294096.0 for Q4 2025, up 259.57% from a year ago — trailing twelve months through Dec 2025 was $677000.0 (up 339.61% YoY), and the annual figure for FY2025 was $677000.0, up 339.61%.
- Depreciation & Amortization (CF) reached $294096.0 in Q4 2025 per CRMD's latest filing, up from $161917.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $294096.0 in Q4 2025 and bottomed at $11994.0 in Q1 2021.
- Median Depreciation & Amortization (CF) over the past 5 years was $20925.0 (2022), compared with a mean of $52413.2.
- The largest annual shift saw Depreciation & Amortization (CF) tumbled 75.15% in 2021 before it skyrocketed 535.97% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $20047.0 in 2021, then grew by 12.32% to $22516.0 in 2022, then decreased by 17.08% to $18670.0 in 2023, then soared by 338.08% to $81790.0 in 2024, then surged by 259.57% to $294096.0 in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for CRMD at $294096.0 in Q4 2025, $161917.0 in Q3 2025, and $110993.0 in Q2 2025.